Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Guerbet
Information provided by (Responsible Party):
Yale University
ClinicalTrials.gov Identifier:
NCT01877187
First received: March 27, 2013
Last updated: April 21, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)